SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-19-006626
Filing Date
2019-05-21
Accepted
2019-05-21 14:15:32
Documents
14
Period of Report
2019-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp107067_6k.htm 6-K 158553
2 GRAPHIC image_001.jpg GRAPHIC 5646
3 GRAPHIC image_002.jpg GRAPHIC 5645
4 GRAPHIC image_003.jpg GRAPHIC 5645
5 GRAPHIC image_004.jpg GRAPHIC 5645
6 GRAPHIC image_005.jpg GRAPHIC 5624
7 GRAPHIC image_006.jpg GRAPHIC 5645
8 GRAPHIC image_007.jpg GRAPHIC 5678
9 GRAPHIC image_008.jpg GRAPHIC 5678
10 GRAPHIC image_009.jpg GRAPHIC 5678
11 GRAPHIC image_010.jpg GRAPHIC 5678
12 GRAPHIC image_011.jpg GRAPHIC 5678
13 GRAPHIC image_012.jpg GRAPHIC 5678
14 GRAPHIC image_013.jpg GRAPHIC 5678
  Complete submission text file 0000950103-19-006626.txt   262658
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 19841880
SIC: 2834 Pharmaceutical Preparations